The Role of the Breast Cancer Resistance Protein (ABCG2) in the Distribution of Sorafenib to the Brain-Reference-Cited by-同舟云学术

The Role of the Breast Cancer Resistance Protein (ABCG2) in the Distribution of Sorafenib to the Brain

Published:2010-10-15 Issue:1 Volume:336 Page:223-233
ISSN:0022-3565
Container-title:Journal of Pharmacology and Experimental Therapeutics
language:en
Short-container-title:J Pharmacol Exp Ther

Author:

Agarwal Sagar,Sane Ramola,Ohlfest John R.,Elmquist William F.

Publisher

American Society for Pharmacology & Experimental Therapeutics (ASPET)

Subject

Pharmacology,Molecular Medicine

Reference43 articles.

1. Distribution of Gefitinib to the Brain Is Limited by P-glycoprotein (ABCB1) and Breast Cancer Resistance Protein (ABCG2)-Mediated Active Efflux

2. Role Reversal for Anticancer Agents

3. Testing for the equality of area under the curves when using destructive measurement techniques

4. ABC Transporters and the Blood-Brain Barrier

5. Bellmunt J Eisen T Fishman M Quinn D (2010) Experience with sorafenib and adverse event management. Crit Rev Oncol Hematol doi:10.1016/j.critrevonc.2010,03.006 .

Cited by 145 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Targeting Intracranial Tumours with a Combination of RNA and Chemotherapy;Pharmaceutics;2024-06-18

2. Phase 2 Study of Sorafenib, Valproic Acid, and Sildenafil in the Treatment of Recurrent High-Grade Glioma;2024-04-24

3. Blood–brain barrier transporters: a translational consideration for CNS delivery of neurotherapeutics;Expert Opinion on Drug Delivery;2024-01-02

4. Qbd Driven Bioanalytical Hplc Method Validation of Sorafenib: Application to Comparative Pharmacokinetics;2024

5. Potential of African plants and their derived phytochemicals against hepatocellular carcinoma;Advances in Botanical Research;2024